tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
Arcus Biosciences files automatic mixed securities shelf
PremiumThe FlyArcus Biosciences files automatic mixed securities shelf
19d ago
Buy Rating on Arcus Biosciences Driven by Best-in-Class Casdatifan Data in Renal Cell Carcinoma and Favorable Phase 3 Risk‑Reward
Premium
Ratings
Buy Rating on Arcus Biosciences Driven by Best-in-Class Casdatifan Data in Renal Cell Carcinoma and Favorable Phase 3 Risk‑Reward
20d ago
Arcus’s Lead HIF-2α Inhibitor Delivers Superior Late-Line RCC Efficacy, De-Risking PEAK-1 and Supporting Buy Rating
Premium
Ratings
Arcus’s Lead HIF-2α Inhibitor Delivers Superior Late-Line RCC Efficacy, De-Risking PEAK-1 and Supporting Buy Rating
20d ago
Midday Fly By: JPMorgan reports mixed Q4, L3Harris to form new missile company
PremiumThe FlyMidday Fly By: JPMorgan reports mixed Q4, L3Harris to form new missile company
2M ago
Arcus Biosciences upgraded to Buy from Neutral at Goldman Sachs
Premium
The Fly
Arcus Biosciences upgraded to Buy from Neutral at Goldman Sachs
2M ago
Arcus Biosciences downgraded to Equal Weight from Overweight at Morgan Stanley
Premium
The Fly
Arcus Biosciences downgraded to Equal Weight from Overweight at Morgan Stanley
2M ago
Arcus Biosciences Amends Loan Facility, Extends Maturity Terms
PremiumCompany AnnouncementsArcus Biosciences Amends Loan Facility, Extends Maturity Terms
3M ago
Morning News Wrap-Up: Friday’s Biggest Stock Market Stories!
Premium
Market News
Morning News Wrap-Up: Friday’s Biggest Stock Market Stories!
3M ago
Arcus Biosciences price target lowered to $44 from $56 at Citi
Premium
The Fly
Arcus Biosciences price target lowered to $44 from $56 at Citi
3M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100